
News
Home>News & Events>Press Releases>C-Path>Critical Path Institute Receives Grant to Accelerate Development of Tuberculosis Treatments
85,50
Related Posts
-
Global Health Partners Accelerate Uptake of Genetic Sequencing for Surveillance And Diagnosis Of Drug-Resistant Tuberculosis
-
European Medicines Agency Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug Development
-
Critical Path Institute Receives Third Grant To Accelerate Tuberculosis Diagnostics
-
CPTR Initiative Expands Focus to Include Drug Susceptibility Tests
-
Launch of the Good Participatory Practice Guidelines for TB Drug Trials